Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1827047
PUBLISHER: BCC Research | PRODUCT CODE: 1827047
Artificial Intelligence (AI) in Pharmaceuticals: Global Markets
PUBLISHED:
PAGES: 139 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for artificial intelligence (AI) in pharmaceuticals is estimated to grow from $3.8 billion in 2025 to reach $15.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 31.7% from 2025 through 2030.
The North American market for AI in pharmaceuticals is estimated to grow from $2.3 billion in 2025 to reach $9.6 billion by the end of 2030, at a CAGR of 32.9% from 2025 through 2030.
The Asia-Pacific market for AI in pharmaceuticals is estimated to grow from $496.3 million in 2025 to reach $2.3 billion by the end of 2030, at a CAGR of 36.0% from 2025 through 2030.
Report Scope
This report on the global market for AI in pharmaceuticals explores market dynamics and trends, and analyzes technological developments, software performance, clinical trials, new product approvals and emerging technologies. The report also includes profiles of leading companies and their strategies.
The report explores how AI is transforming the pharmaceutical industry through enhanced diagnostic capabilities, early disease detection, clinical trial optimization, drug discovery and personalized treatment planning. It also examines AI disruption across industry verticals and value chain stages, while presenting market spending patterns, investment forecasts, R&D expenditures and venture capital funding. The report segments the market by product type, application and region. Types include software and services. Applications include drug discovery and development, clinical trials, personalized medicines and others. The four regions covered are North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data has been provided for 2024 as the base year, with forecasts for 2025 through 2030.
Report Includes
- 27 data tables and 62 additional tables
- An analysis of the global markets for artificial intelligence (AI) in the pharmaceuticals industry
- Analyses of the global market trends, with historic revenue (sales figures) from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
- Estimates of the market's size and revenue growth prospects, accompanied by a market share analysis by product type, application and region
- Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impacts of macroeconomic variables
- Insights derived from Porter's Five Forces model, as well as a global supply chain analysis
- Case studies on AI implementation to streamline processes across drug discovery and development, manufacturing, quality control and patient care
- A relevant patent analysis, featuring key granted and published patents
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Analysis of the industry structure, including companies' market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
- Profiles of the leading companies, including Google DeepMind, Atomwise Inc., Insilico Medicine, Recursion Pharmaceuticals and Nvidia Corp.
Product Code: AIT020A
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Current Market Overview
- Macroeconomic Factors Analysis
- Government Policy and Regulation
- Technological Infrastructure and Digital Readiness
- Global Trade and Supply Chain Dynamics
- Impact of U.S. Tariffs
- Porter's Five Forces Analysis
- Potential for New Entrants (Moderate to High)
- Bargaining Power of Suppliers (Low to Moderate)
- Bargaining Power of Buyers (High)
- Threat of Substitute Products or Services (Low to Moderate)
- Industry Level of Competitiveness (High)
- AI's Impact on the Pharmaceutical Value Chain
- Drug Discovery and Preclinical Development: Accelerated Innovation
- Clinical Trials: Smarter Design and Execution
- Manufacturing and Supply Chain: Intelligent Operations
- Regulatory Affairs and Compliance: Automation and Accuracy
- Commercialization and Market Access: Data-Driven Strategies
- Post-Market Surveillance: Continuous Learning and Safety Monitoring
- Use Cases
- Use Case 1: Generative AI for Efficiency in Regulatory Submissions
- Use Case 2: Generative AI-Enabled R&D Assistant for Synthesis Routes
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Faster Drug Discovery and Development
- Increasing Adoption of AI in Clinical Trials
- Demand for Precision Medicine and AI Applications
- Market Restraints
- Regulatory and Ethical Concerns
- Data Challenges
- Market Opportunities
- Collaborations and Investments
- Increased Focus on Drug Discovery in Emerging Nations
- Advances of Generative AI in Molecular Design
Chapter 4 Regulatory Landscape
- Overview
- Regulatory Scenario in the U.S.
- Regulatory Scenario in Europe
- Regulatory Scenario in Japan
- Regulatory Scenario in China
- Other Countries
Chapter 5 Emerging Trends and Pipeline Analysis
- Emerging Trends
- Generative AI in Pharma
- Federated Learning
- Natural Language Processing
- Generative Adversarial Networks
- Pipeline Analysis
- Takeaways
- Patent Analysis
- Findings
Chapter 6 Market Segment Analysis
- Segmentation Breakdown
- Market Breakdown, by Product Type
- Takeaways
- Software
- Services
- Market Breakdown, by Application
- Takeaways
- Drug Discovery and Development
- Clinical Trials
- Personalized Medicine
- Other Applications
- Geographic Breakdown
- Market Breakdown, by Region
- Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 7 Competitive Intelligence
- Takeaways
- Competitive Analysis
- Strategic Analysis
- Investment Landscape
Chapter 8 Sustainability in AI in the Pharmaceutical Industry: ESG Perspective
- Introduction to ESG
- Sustainability Trends and Initiatives
- ESG Risk Ratings
- Concluding Remarks from BCC Research
Chapter 9 Appendix
- Research Methodology
- Sources
- Abbreviations
- Company Profiles
- AICURE
- ATOMWISE INC.
- BENEVOLENTAI
- GOOGLE DEEPMIND
- HEALX
- IKTOS
- INSILICO MEDICINE
- INVENIAI LLC.
- NVIDIA CORP.
- PATHAI INC.
- RECURSION
- SCHRODINGER INC.
- SYRENCLOUD INC.
- TEMPUS AI INC.
- XTALPI INC.
- Emerging Start-ups/Market Disruptors
Product Code: AIT020A
List of Tables
- Summary Table : Global Market for AI in Pharmaceuticals, by Region, Through 2030
- Table 1 : Collaborations Between AI Software and Pharmaceutical Companies
- Table 2 : FDA AI/ML Initiatives and Milestones, 2014 and 2025
- Table 3 : EMA AI/ML Regulatory Development Timeline, 2021-2024
- Table 4 : Clinical Trial Data for AI in Pharmaceutical Drugs, 2025
- Table 5 : Granted Patents for AI in Pharmaceuticals, 2022-2025
- Table 6 : Global Market for AI in Pharmaceuticals, by Product Type, Through 2030
- Table 7 : Global Market for AI Software in Pharmaceuticals, by Region, Through 2030
- Table 8 : Global Market for Services in AI in Pharmaceuticals, by Region, Through 2030
- Table 9 : Global Market for AI in Pharmaceuticals, by Application, Through 2030
- Table 10 : AI Tools Used in Drug Discovery
- Table 11 : AI-Enabled Drugs Entering the Clinical Phase, 2025
- Table 12 : Global Market for AI in Drug Discovery and Development, by Region, Through 2030
- Table 13 : Partnerships Between Pharmaceutical and Technology Companies, 2023-2025
- Table 14 : Advantages and Disadvantages of Using AI in Clinical Trials
- Table 15 : Global Market for AI in Pharmaceuticals for Clinical Trial Applications, by Region, Through 2030
- Table 16 : Applications of ML in Pharmacogenomics
- Table 17 : Global Market for AI in Pharmaceuticals for Personalized Medicine, by Region, Through 2030
- Table 18 : Global Market for Other Applications of AI in Pharmaceuticals, by Region, Through 2030
- Table 19 : Global Market for AI in Pharmaceuticals, by Region, Through 2030
- Table 20 : North American Market for AI in Pharmaceuticals, by Product Type, Through 2030
- Table 21 : North American Market for AI in Pharmaceuticals, by Application, Through 2030
- Table 22 : North American Market for AI in Pharmaceuticals, by Country, Through 2030
- Table 23 : European Market for AI in Pharmaceuticals, by Product Type, Through 2030
- Table 24 : European Market for AI in Pharmaceuticals, by Application, Through 2030
- Table 25 : European Market for AI in Pharmaceuticals, by Country, Through 2030
- Table 26 : Asia-Pacific Market for AI in Pharmaceuticals, by Product Type, Through 2030
- Table 27 : Asia-Pacific Market for AI in Pharmaceuticals, by Application, Through 2030
- Table 28 : Asia-Pacific Market for AI in Pharmaceuticals, by Country, Through 2030
- Table 29 : RoW Market for AI in Pharmaceuticals, by Product Type, Through 2030
- Table 30 : RoW Market for AI in Pharmaceuticals, by Application, Through 2030
- Table 31 : RoW Market for AI in Pharmaceuticals, by Sub-Region, Through 2030
- Table 32 : Leading Companies in the Global Market for AI in Pharmaceuticals, 2024
- Table 33 : Agreements, Collaborations and Partnerships in the Market for AI in Pharmaceuticals, 2022-2025
- Table 34 : M&A in the AI in Pharmaceuticals Industry, 2024-2025
- Table 35 : Recent Investments in the AI in Pharmaceuticals Industry, 2024 and 2025
- Table 36 : ESG Risk Rankings for AI in Pharmaceuticals Companies, 2025*
- Table 37 : Information Sources Used in this Report
- Table 38 : Abbreviations Used in this Report
- Table 39 : AiCure: Company Snapshot
- Table 40 : AiCure: Product Portfolio
- Table 41 : AiCure: News/Key Developments, 2024
- Table 42 : Atomwise Inc.: Company Snapshot
- Table 43 : Atomwise Inc.: Product Portfolio
- Table 44 : Atomwise Inc.: News/Key Developments, 2022
- Table 45 : BenevolentAI: Company Snapshot
- Table 46 : BenevolentAI: Product Portfolio
- Table 47 : BenevolentAI: News/Key Developments, 2022-2025
- Table 48 : Google DeepMind: Company Snapshot
- Table 49 : Google DeepMind: Product Portfolio
- Table 50 : Google DeepMind: News/Key Developments, 2024 and 2025
- Table 51 : Healx: Company Snapshot
- Table 52 : Healx: Product Portfolio
- Table 53 : Healx: News/Key Developments, 2023 and 2024
- Table 54 : Iktos: Company Snapshot
- Table 55 : Iktos: Product Portfolio
- Table 56 : Iktos: News/Key Developments, 2023-2025
- Table 57 : Insilico Medicine: Company Snapshot
- Table 58 : Insilico Medicine: Product Portfolio
- Table 59 : Insilico Medicine: News/Key Developments, 2023-2025
- Table 60 : InveniAI LLC.: Company Snapshot
- Table 61 : InveniAI LLC.: Product Portfolio
- Table 62 : InveniAI LLC.: News/Key Developments, 2021-2024
- Table 63 : Nvidia Corp.: Company Snapshot
- Table 64 : Nvidia Corp.: Financial Performance, FY 2023 and 2024
- Table 65 : Nvidia Corp.: Product Portfolio
- Table 66 : Nvidia Corp.: News/Key Developments, 2023-2025
- Table 67 : PathAI Inc.: Company Snapshot
- Table 68 : PathAI Inc.: Product Portfolio
- Table 69 : PathAI Inc.: News/Key Developments, 2024 and 2025
- Table 70 : Recursion: Company Snapshot
- Table 71 : Recursion: Financial Performance, FY 2023 and 2024
- Table 72 : Recursion: Product Portfolio
- Table 73 : Recursion: News/Key Developments, 2024 and 2025
- Table 74 : Schrodinger Inc.: Company Snapshot
- Table 75 : Schrodinger Inc.: Financial Performance, FY 2023 and 2024
- Table 76 : Schrodinger Inc.: Product Portfolio
- Table 77 : Schrodinger Inc.: News/Key Developments, 2023 and 2024
- Table 78 : SyrenCloud Inc.: Company Snapshot
- Table 79 : SyrenCloud Inc.: Product Portfolio
- Table 80 : Tempus AI Inc.: Company Snapshot
- Table 81 : Tempus AI Inc.: Financial Performance, FY 2023 and 2024
- Table 82 : Tempus AI Inc.: Product Portfolio
- Table 83 : Tempus AI Inc.: News/Key Developments, 2023-2025
- Table 84 : XtalPi Inc.: Company Snapshot
- Table 85 : XtalPi Inc.: Financial Performance, FY 2023 and 2024
- Table 86 : XtalPi Inc.: Product Portfolio
- Table 87 : XtalPi Inc.: News/ Key Developments, 2024 and 2025
- Table 88 : Emerging Startups in the Market for AI in Pharmaceuticals
List of Figures
- Summary Figure : Global Market Shares of AI in Pharmaceuticals, by Region, 2024
- Figure 1 : Applications of AI in the Drug Development and Distribution Life Cycle
- Figure 2 : Porter's Five Forces Analysis: AI in Pharmaceuticals Market
- Figure 3 : Applications of AI in the Pharmaceutical Value Chain
- Figure 4 : Market Dynamics of AI in Pharmaceuticals
- Figure 5 : Emerging Technologies of AI in the Pharmaceutical Market
- Figure 6 : Granted Patents for AI in Pharmaceuticals, by Year, 2021-2025
- Figure 7 : Global Market Shares of AI in Pharmaceuticals, by Product Type, 2024
- Figure 8 : Global Market Shares of AI Software in Pharmaceuticals, by Region, 2024
- Figure 9 : Global Market Shares of Services for AI in Pharmaceuticals, by Region, 2024
- Figure 10 : Global Market Shares of AI in Pharmaceuticals, by Application, 2024
- Figure 11 : Role of AI in Drug Discovery
- Figure 12 : Global Market Shares of AI in Drug Discovery and Development, by Region, 2024
- Figure 13 : Global Market Shares of AI in Pharmaceuticals for Clinical Trial Applications, by Region, 2024
- Figure 14 : Global Market Shares of AI in AI in Pharmaceuticals for Personalized Medicine, by Region, 2024
- Figure 15 : Global Market Shares of Other Applications of AI in Pharmaceuticals, by Region, 2024
- Figure 16 : Global Market Shares of AI in Pharmaceuticals, by Region, 2024
- Figure 17 : North American Market Shares of AI in Pharmaceuticals, by Product Type, 2024
- Figure 18 : North American Market Shares of AI in Pharmaceuticals, by Application, 2024
- Figure 19 : North American Market Shares of AI in Pharmaceuticals, by Country, 2024
- Figure 20 : European Market Shares of AI in Pharmaceuticals, by Product Type, 2024
- Figure 21 : European Market Shares of AI in Pharmaceuticals, by Application, 2024
- Figure 22 : European Market Shares of AI in Pharmaceuticals, by Country, 2024
- Figure 23 : Asia-Pacific Market Shares of AI in Pharmaceuticals, by Product Type, 2024
- Figure 24 : Asia-Pacific Market Shares of AI in Pharmaceuticals, by Application, 2024
- Figure 25 : Asia-Pacific Market Shares of AI in Pharmaceuticals, by Country, 2024
- Figure 26 : RoW Market Shares of AI in Pharmaceuticals, by Product Type, 2024
- Figure 27 : RoW Market Shares of AI in Pharmaceuticals, by Application, 2024
- Figure 28 : RoW Market Shares of AI in Pharmaceuticals, by Sub-Region, 2024
- Figure 29 : Biopharma AI Investment, 2019-2024
- Figure 30 : Nvidia Corp.: Revenue Share, by Business Unit, FY 2024
- Figure 31 : Nvidia Corp.: Revenue Share by Country/Region, FY 2024
- Figure 32 : Schrodinger Inc.: Revenue Share, by Business Unit, FY 2024
- Figure 33 : Schrodinger Inc.: Revenue Share, by Country/Region, FY 2024
- Figure 34 : Tempus AI Inc.: Revenue Share, by Business Unit, FY 2024
- Figure 35 : XtalPi Inc.: Revenue Share, by Business Unit, FY 2024
- Figure 36 : XtalPi Inc.: Revenue Share, by Country/Region, FY 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.